- The role of therapeutic drug monitoring in mycobacterial infections
- The public health issues of refugees and migrants, and their exposure and transmission of tuberculosis resulting from humanitarian crises
- Diabetes mellitus as a significant risk factor for tuberculosis
- The increased risk of tuberculosis reactivation in people taking tumor necrosis factor alpha inhibitors and other biopharmaceuticals Other chapters provide detailed information on the clinical, public health, and policy aspects of tracking and treating tuberculosis, including:
- The many presentations of tuberculosis, from pulmonary to ocular and cardiovascular to urogenital
- The complications that tuberculosis and antituberculosis therapy cause to the hematologic and endocrine systems
- Tuberculosis during pregnancy and in infants and children
- Treatment of multidrug-resistant tuberculosis and extensively drugresistant tuberculosis
- Development of new vaccines
- Nontuberculous infections caused by mycobacteria found throughout our environment
The seventh edition of Tuberculosis and Nontuberculous Mycobacterial Infections is an essential resource for anyone working to prevent and treat tuberculosis and associated infections, from infectious disease specialists to scientists, policymakers, and epidemiologists.
